Document is current
Any future updates will be listed below
-
Authors
Boerlage, Thomas C. C.
Haal, Sylke
Maurits de Brauw, L.
Acherman, Yair I. Z.
Bruin, Sjoerd
van de Laar, Arnold W. J. M.
Moes, Daan E.
van Wagensveld, Bart A.
de Vries, Claire E. E.
van Veen, Ruben
Schouten, Ruben
Dijkgraaf, Marcel G.
Fockens, Paul
Gerdes, Victor E. A.
Voermans, Rogier P.
-
Funding
Funding for this research was provided by:
Zambon BV
ZonMw (848015003)
- License Information
-
More Information
Article History
Received: 13 April 2017
Accepted: 10 November 2017
First Online: 20 December 2017
Ethics approval and consent to participate
: All participants will give written informed consent. The study protocol was reviewed and approved by the medical research ethics committee of the MC Slotervaart / Reade (number P1661), and authorized by the competent authority in accordance with the Dutch Medical Research Involving Human Subjects Act (WMO).
: Not applicable.
: Zambon BV the Netherlands provided research support by providing the study medication for this trial. The authors declare that they have no further competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
